Daniele Santini

Multivariate prognostic factors analysis for second-line chemotherapy in advanced biliary tract cancer

E. Vasile, G. Fasola, G. Brandi, 2014, British Journal of Cancer.

Prognosis of mucinous histology for patients with radically resected stage II and III colon cancer.

V. Catalano, D. Rossi, B. Vincenzi, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Management of metastatic renal cell carcinoma patients with poor-risk features: current status and future perspectives

M. Milella, M. Santoni, D. Santini, 2013, Expert review of anticancer therapy.

High prevalence of retinoblastoma protein loss in triple-negative breast cancers and its association with a good prognosis in patients treated with adjuvant chemotherapy.

L. Montanaro, D. Treré, M. Derenzini, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Capecitabine with/without mitomycin C: results of a randomized phase II trial of second-line therapy in advanced biliary tract adenocarcinoma

E. Vasile, M. Reni, D. Santini, 2015, Cancer Chemotherapy and Pharmacology.

The prognostic and predictive role of hyponatremia in patients with advanced non-small cell lung cancer (NSCLC) with bone metastases

R. Berardi, I. Fiordoliva, F. Morgese, 2018, Supportive Care in Cancer.